1. Qin, Fujun, Zhang, Yanmei, Liu, Jia, Li, Hui. 2017. SLC45A3-ELK4 functions as a long non-coding chimeric RNA. In Cancer letters, 404, 53-61. doi:10.1016/j.canlet.2017.07.007. https://pubmed.ncbi.nlm.nih.gov/28716526/
2. Zhang, Yi, Zeng, Hanhai, Lou, Feiyang, Zhang, Xiaotong, Chen, Gao. 2023. SLC45A3 Serves as a Potential Therapeutic Biomarker to Attenuate White Matter Injury After Intracerebral Hemorrhage. In Translational stroke research, 15, 556-571. doi:10.1007/s12975-023-01145-5. https://pubmed.ncbi.nlm.nih.gov/36913120/
3. Kumar-Sinha, Chandan, Kalyana-Sundaram, Shanker, Chinnaiyan, Arul M. . SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing. In Cancer discovery, 2, 582-5. doi:10.1158/2159-8290.CD-12-0212. https://pubmed.ncbi.nlm.nih.gov/22787087/
4. Rickman, David S, Pflueger, Dorothee, Moss, Benjamin, Demichelis, Francesca, Rubin, Mark A. 2009. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. In Cancer research, 69, 2734-8. doi:10.1158/0008-5472.CAN-08-4926. https://pubmed.ncbi.nlm.nih.gov/19293179/
5. Qin, Fujun, Song, Yansu, Zhang, Yanmei, Frierson, Henry, Li, Hui. 2016. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA. In PloS one, 11, e0150382. doi:10.1371/journal.pone.0150382. https://pubmed.ncbi.nlm.nih.gov/26938874/
6. Vitavska, Olga, Edemir, Bayram, Wieczorek, Helmut. 2016. Putative role of the H(+)/sucrose symporter SLC45A3 as an osmolyte transporter in the kidney. In Pflugers Archiv : European journal of physiology, 468, 1353-62. doi:10.1007/s00424-016-1841-6. https://pubmed.ncbi.nlm.nih.gov/27228996/
7. Hernández, Silvia, Font-Tello, Alba, Juanpere, Núria, Serrano, Sergio, Lloreta, Josep. 2016. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset. In The Prostate, 76, 854-65. doi:10.1002/pros.23176. https://pubmed.ncbi.nlm.nih.gov/26959281/
8. Esgueva, Raquel, Perner, Sven, J LaFargue, Christopher, Kristiansen, Glen, Rubin, Mark A. 2010. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 23, 539-46. doi:10.1038/modpathol.2009.193. https://pubmed.ncbi.nlm.nih.gov/20118910/
9. Shin, D, Howng, S Y B, Ptáček, L J, Fu, Y-H. 2012. miR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin. In Neuroscience, 213, 29-37. doi:10.1016/j.neuroscience.2012.03.054. https://pubmed.ncbi.nlm.nih.gov/22521588/